ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings
Benzinga ยท 303 days
AI Summary
RMD reported Q2 earnings of $2.55, beating estimates. Sales were $1.348 billion, surpassing analyst predictions. Analysts raised price targets post-earnings, reflecting positive sentiment. Shares rose 2.1% following the earnings announcement. Demand for sleep and breathing health devices drove growth.
Sentiment Rationale
Earnings beat and positive analyst revisions likely to drive RMD's stock price higher. Historical context shows similar earnings beats led to sustained upward movements in stock prices.
Trading Thesis
Immediate market reactions are typically seen within days following earnings announcements. Future earnings will continue to affect long-term outlook, but initial momentum is short-term.
Market-Moving
- RMD reported Q2 earnings of $2.55, beating estimates.
- Sales were $1.348 billion, surpassing analyst predictions.
- Analysts raised price targets post-earnings, reflecting positive sentiment.
Key Facts
- RMD reported Q2 earnings of $2.55, beating estimates.
- Sales were $1.348 billion, surpassing analyst predictions.
- Analysts raised price targets post-earnings, reflecting positive sentiment.
- Shares rose 2.1% following the earnings announcement.
- Demand for sleep and breathing health devices drove growth.
Companies Mentioned
- Piper Sandler (Piper Sandler)
- Keybanc (Keybanc)
- UBS (UBS)
- RBC Capital (RBC Capital)
- Stifel (Stifel)
- Mizuho (Mizuho)
Earnings
The better-than-expected earnings and subsequent revisions from analysts signal strong financial health of RMD, influencing investor decisions and stock performance.